The pharmaceutical landscape is constantly shifting, with mergers and acquisitions being a regular occurrence. In this dynamic environment, Wockhardt has emerged as a potential strategic opportunity for various players in the market. Several factors contribute to this interest, including its strong portfolio of generic drugs and its footprint acro